Amyloid fibrils and soluble oligomers are two types of protein aggregates associated with neurodegeneration. Classic therapeutic strategies try to prevent the nucleation and spread of amyloid fibrils, whilst diffusible oligomers have emerged as promising drug targets affecting downstream pathogenic processes. We developed a generic protein aggregation model and validate it against measured compositions of fibrillar and non-fibrillar assemblies of ataxin-3, a protein implicated in Machado-Joseph disease. The derived analytic rate-law equations can be used to 1) identify the presence of parallel aggregation pathways and 2) estimate the critical sizes of amyloid fibrils. The discretized population balance supporting our model is the first to q...
Alzheimer’s disease, type II diabetes, and other amyloid diseases are known to be associated with th...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the c...
Drug discovery frequently relies on the kinetic analysis of physicochemical reactions that are at t...
Drug discovery frequently relies on the kinetic analysis of physicochemical reactions that are at th...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Protein self-assembly into amyloid fibrils underlies several neurodegenerative conditions, including...
We combine atomic-force-microscopy particle-size-distribution measurements with earlier measurements...
The spontaneous assembly of proteins into amyloid fibrils is a phenomenon central to many increasing...
The molecular mechanism of protein aggregation is of both fundamental and clinical importance as amy...
Insoluble aggregates staining positive to amyloid dyes are known histological hallmarks of different...
Alzheimer’s disease (AD)-associated amyloid β peptide (Aβ) is one of the main actors in AD pathogene...
The molecular mechanism of protein aggregation is of both fundamental and clinical importance as amy...
International audienceAlzheimer's disease (AD)-associated amyloid β peptide (Aβ) is one of the main ...
Alzheimer’s disease, type II diabetes, and other amyloid diseases are known to be associated with th...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the c...
Drug discovery frequently relies on the kinetic analysis of physicochemical reactions that are at t...
Drug discovery frequently relies on the kinetic analysis of physicochemical reactions that are at th...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Protein self-assembly into amyloid fibrils underlies several neurodegenerative conditions, including...
We combine atomic-force-microscopy particle-size-distribution measurements with earlier measurements...
The spontaneous assembly of proteins into amyloid fibrils is a phenomenon central to many increasing...
The molecular mechanism of protein aggregation is of both fundamental and clinical importance as amy...
Insoluble aggregates staining positive to amyloid dyes are known histological hallmarks of different...
Alzheimer’s disease (AD)-associated amyloid β peptide (Aβ) is one of the main actors in AD pathogene...
The molecular mechanism of protein aggregation is of both fundamental and clinical importance as amy...
International audienceAlzheimer's disease (AD)-associated amyloid β peptide (Aβ) is one of the main ...
Alzheimer’s disease, type II diabetes, and other amyloid diseases are known to be associated with th...
Amyloid deposition has been observed in more than 20 diseases. Each amyloid-related dis...
Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the c...